Effectiveness and safety of secukinumab in ankylosing spondylitis and psoriatic arthritis: a 52-week real-life study in an Italian cohort

Overview of attention for article published in Advances in Rheumatology, March 2023

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (83rd percentile)

Mentioned by

news: 1 news outlet

twitter: 1 X user

Citations

dimensions_citation: 4 Dimensions

Readers on

mendeley: 13 Mendeley

Summary News X Dimensions citations

So far, Altmetric has seen 1 news story.

Secukinumab Demonstrates Safety, Efficacy in Patients with Ankylosing Spondylitis, Psoriatic Arthritis

HCP Live, 30 Mar 2023

Treatment with secukinumab was proven to be a safe and effective option for patients with ankylosing spondylitis (AS) and…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.